Bare Financial Services
TGTX icon

Bare Financial Services’s TG Therapeutics TGTX Stock Holding History

Bare Financial Services’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.3K Buy
454
+56
+14% +$3.03K 0.01% 208
2026
Q2 		$21.9K Buy
398
+172
+76% +$7.04K 0.01% 242
2026
Q1 		$7.51K Buy
226
+50
+28% +$1.49K ﹤0.01% 482
2025
Q4 		$5.25K Sell
176
-27
-13% -$882 ﹤0.01% 521
2025
Q3 		$7.33K Buy
203
+7
+4% +$231 ﹤0.01% 365
2025
Q2 		$7.05K Buy
196
+138
+238% +$5.14K ﹤0.01% 305
2025
Q1 		$2.29K Buy
+58
New +$1.95K ﹤0.01% 229

Other funds holding TGTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Penn Capital Management
Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Bare Financial Services's TGTX Position: Q3 2026 in Review

Bare Financial Services increased its TG Therapeutics (TGTX) stake by 14% in Q3 2026, buying an estimated $3.03K and bringing the position to 454 shares worth $25.3K. The position accounts for 0.01% of the portfolio, ranked #208.

Bare Financial Services first reported a position in TGTX in Q1 2025 and has held it in 7 quarters since. 197 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Bare Financial Services held 454 shares of TG Therapeutics worth $25.3K as of Q3 2026.
  • Bare Financial Services bought 56 TG Therapeutics shares in Q3 2026, an estimated $3.03K.
  • TG Therapeutics made up 0.01% of Bare Financial Services's portfolio in Q3 2026, its #208 holding.
  • Bare Financial Services first reported a position in TG Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • 197 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.